Basic Information
| RNALocate ID: | RLID:01001580 |
| RNA Symbol: | hsa-miR-30c-5p |
| Localization: | Nucleus |
RNA Information
| RNA Name: | hsa-miR-30c |
| RNA ID: | miRBase:MIMAT0000244 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 21363885 |
| Tissue/Cell Line: | Neural progenitor cells |
| Method: | Microarray|qRT-PCR |
| Description: | The miRNAs with nuclear or cytoplasmic dominance are shown in Table 1 (complete data in Supplement 4). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001571 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001572 | Cytoplasm | Cell line (HeLa) | 21695135 |
| RLID:01001573 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001574 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001575 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001576 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001577 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001578 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001579 | Nucleus | Colon adenocarcinoma cells | 20864815 |
| RLID:11001327 | Exosome | Human cervical cancer cell line (HeLa) | 25760330 |
| RLID:11001328 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11001329 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11001330 | Exosome | Brain tissue | 23382797 |
| RLID:11001331 | Exosome | Plasma | 23663360 |
| RLID:11001332 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11001333 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000042 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Endothelial cells|Epithelial cells|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000311 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-30c-5p | Splenic marginal zone lymphoma | MNDR-E-MI-37242 |
| MNDR | hsa-miR-30c-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-37243 |
| MNDR | hsa-miR-30c-5p | Glomerulosclerosis | MNDR-E-MI-37244 |
| MNDR | hsa-miR-30c-5p | Oral squamous cell carcinoma | MNDR-E-MI-37245 |
| MNDR | hsa-miR-30c-5p | Large cell neuroendocrine cancer | MNDR-E-MI-37246 |
| MNDR | hsa-miR-30c-5p | Medulloblastoma | MNDR-E-MI-37247 |
| MNDR | hsa-miR-30c-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-37248 |
| MNDR | hsa-miR-30c-5p | Lymphoma | MNDR-E-MI-37249 |
| MNDR | hsa-miR-30c-5p | Lymphoma non-hodgkin | MNDR-E-MI-37250 |
| MNDR | hsa-miR-30c-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-37251 |
| MNDR | hsa-miR-30c-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-37252 |
| MNDR | hsa-miR-30c-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-37253 |
| MNDR | hsa-miR-30c-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-37254 |
| MNDR | hsa-miR-30c-5p | Her2-receptor positive breast cancer | MNDR-E-MI-37255 |
| MNDR | hsa-miR-30c-5p | Niemann-pick disease type c | MNDR-E-MI-37256 |
| MNDR | hsa-miR-30c-5p | Miyoshi myopathy | MNDR-E-MI-37257 |
| MNDR | hsa-miR-30c-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-37258 |
| MNDR | hsa-miR-30c-5p | Dermatomyositis | MNDR-E-MI-37259 |
| MNDR | hsa-miR-30c-5p | Prostate cancer | MNDR-E-MI-37260 |
| MNDR | hsa-miR-30c-5p | Gastric cancer | MNDR-E-MI-37261 |
| MNDR | hsa-miR-30c-5p | Alzheimer disease | MNDR-E-MI-37262 |
| MNDR | hsa-miR-30c-5p | Intracranial aneurysm | MNDR-E-MI-37263 |
| MNDR | hsa-miR-30c-5p | Bladder cancer | MNDR-E-MI-37264 |
| MNDR | hsa-miR-30c-5p | Esophageal carcinoma | MNDR-E-MI-37265 |
| MNDR | hsa-miR-30c-5p | Dysautonomia familial | MNDR-E-MI-37266 |
| MNDR | hsa-miR-30c-5p | Distal muscular dystrophy | MNDR-E-MI-37267 |
| MNDR | hsa-miR-30c-5p | Duchenne muscular dystrophy | MNDR-E-MI-37268 |
| MNDR | hsa-miR-30c-5p | Head and neck cancer | MNDR-E-MI-37269 |
| MNDR | hsa-miR-30c-5p | Huntington disease | MNDR-E-MI-37270 |
| MNDR | hsa-miR-30c-5p | Chorea | MNDR-E-MI-37271 |
| MNDR | hsa-miR-30c-5p | Cardiovascular disease | MNDR-E-MI-37272 |
| MNDR | hsa-miR-30c-5p | Carotid stenosis | MNDR-E-MI-37273 |
| MNDR | hsa-miR-30c-5p | Lung cancer | MNDR-E-MI-37274 |
| MNDR | hsa-miR-30c-5p | Endometrial cancer | MNDR-E-MI-37275 |
| MNDR | hsa-miR-30c-5p | Down syndrome | MNDR-E-MI-37276 |
| MNDR | hsa-miR-30c-5p | Parkinson disease | MNDR-E-MI-37277 |
| MNDR | hsa-miR-30c-5p | Niemann-pick disease | MNDR-E-MI-37278 |
| MNDR | hsa-miR-30c-5p | Breast cancer | MNDR-E-MI-37279 |
| MNDR | hsa-miR-30c-5p | Pancreatic cancer | MNDR-E-MI-37280 |
| MNDR | hsa-miR-30c-5p | Melanoma | MNDR-E-MI-37281 |
| MNDR | hsa-miR-30c-5p | Rectum adenocarcinoma | MNDR-E-MI-37282 |
| MNDR | hsa-miR-30c-5p | Nephroblastoma | MNDR-E-MI-37283 |
| MNDR | hsa-miR-30c-5p | Colon cancer | MNDR-E-MI-37284 |
| MNDR | hsa-miR-30c-5p | Colon adenocarcinoma | MNDR-E-MI-37285 |
| MNDR | hsa-miR-30c-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-37286 |
| MNDR | hsa-miR-30c-5p | Familial ovarian cancer | MNDR-E-MI-37287 |
| MNDR | hsa-miR-30c-5p | Prostate adenocarcinoma | MNDR-E-MI-37288 |
| MNDR | hsa-miR-30c-5p | Cerebellar disease | MNDR-E-MI-37289 |
| MNDR | hsa-miR-30c-5p | Carcinoma ductal breast | MNDR-E-MI-37290 |
| MNDR | hsa-miR-30c-5p | Glioblastoma | MNDR-E-MI-37291 |
| MNDR | hsa-miR-30c-5p | Astrocytoma | MNDR-E-MI-37292 |
| MNDR | hsa-miR-30c-5p | Glioma | MNDR-E-MI-37293 |
| MNDR | hsa-miR-30c-5p | Central nervous system lymphoma | MNDR-E-MI-37294 |
| MNDR | hsa-miR-30c-5p | Chordoma | MNDR-E-MI-37295 |
| MNDR | hsa-miR-30c-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-37296 |
| MNDR | hsa-miR-30c-5p | Osteosarcoma | MNDR-E-MI-37297 |
| MNDR | hsa-miR-30c-5p | Inclusion body myositis | MNDR-E-MI-37298 |
| MNDR | hsa-miR-30c-5p | Meningioma | MNDR-E-MI-37299 |
| MNDR | hsa-miR-30c-5p | Liver cancer | MNDR-E-MI-37300 |
| MNDR | hsa-miR-30c-5p | Gastric adenocarcinoma | MNDR-E-MI-37301 |
| MNDR | hsa-miR-30c-5p | Cervical squamous cell carcinoma | MNDR-E-MI-37302 |
| MNDR | hsa-miR-30c-5p | Lung squamous cell carcinoma | MNDR-E-MI-37303 |
| MNDR | hsa-miR-30c-5p | Carcinoma lung non-small-cell | MNDR-E-MI-37304 |
| MNDR | hsa-miR-30c-5p | Lung adenocarcinoma | MNDR-E-MI-37305 |
| MNDR | hsa-miR-30c-5p | Thyroid carcinoma | MNDR-E-MI-37306 |
| MNDR | hsa-miR-30c-5p | Ovarian carcinoma | MNDR-E-MI-37307 |
| MNDR | hsa-miR-30c-5p | Bladder urothelial carcinoma | MNDR-E-MI-37308 |
| MNDR | hsa-miR-30c-5p | Liver disease | MNDR-E-MI-37309 |
| MNDR | hsa-miR-30c-5p | Carcinoma renal cell | MNDR-E-MI-37310 |
| MNDR | hsa-miR-30c-5p | Clear cell renal cell carcinoma | MNDR-E-MI-37311 |
| MNDR | hsa-miR-30c-5p | Large cell carcinoma | MNDR-E-MI-37312 |
| MNDR | hsa-miR-30c-5p | Biliary tract cancer | MNDR-E-MI-37313 |
| MNDR | hsa-miR-30c-5p | Cholangiocarcinoma | MNDR-E-MI-37314 |
| MNDR | hsa-miR-30c-5p | Esophageal cancer | MNDR-E-MI-37315 |
| MNDR | hsa-miR-30c-5p | Liver cirrhosis | MNDR-E-MI-37316 |
| MNDR | hsa-miR-30c-5p | Lung small cell carcinoma | MNDR-E-MI-37317 |
| MNDR | hsa-miR-30c-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-37318 |
| MNDR | hsa-miR-30c-5p | Heart failure | MNDR-E-MI-37319 |
| MNDR | hsa-miR-30c-5p | Aortic valve disease | MNDR-E-MI-37320 |
| MNDR | hsa-miR-30c-5p | Encephalomyelitis | MNDR-E-MI-37321 |
| MNDR | hsa-miR-30c-5p | Breast invasive carcinoma | MNDR-E-MI-37322 |
| MNDR | hsa-miR-30c-5p | Early hepatocellular carcinoma | MNDR-E-MI-37323 |
| MNDR | hsa-miR-30c-5p | Familiar ovarian carcinoma | MNDR-E-MI-37324 |
| MNDR | hsa-miR-30c-5p | B-cell lymphoma | MNDR-E-MI-37325 |
| MNDR | hsa-miR-30c-5p | Rheumatoid arthritis | MNDR-E-MI-37326 |
| MNDR | hsa-miR-30c-5p | T-cell leukemia | MNDR-E-MI-37327 |
| MNDR | hsa-miR-30c-5p | Retinoblastoma | MNDR-E-MI-37328 |
| MNDR | hsa-miR-30c-5p | Influenza | MNDR-E-MI-37329 |
| MNDR | hsa-miR-30c-5p | Hodgkin lymphoma | MNDR-E-MI-37330 |
| MNDR | hsa-miR-30c-5p | Burkitt lymphoma | MNDR-E-MI-37331 |
| MNDR | hsa-miR-30c-5p | Tonsil cancer | MNDR-E-MI-37332 |
| MNDR | hsa-miR-30c-5p | Psoriasis | MNDR-E-MI-37333 |
| MNDR | hsa-miR-30c-5p | Colorectal cancer | MNDR-E-MI-37334 |
| MNDR | hsa-miR-30c-5p | Nasopharynx carcinoma | MNDR-E-MI-37335 |
| MNDR | hsa-miR-30c-5p | Multiple myeloma | MNDR-E-MI-37336 |
| MNDR | hsa-miR-30c-5p | Acute lymphocytic leukemia | MNDR-E-MI-37337 |
| MNDR | hsa-miR-30c-5p | Diabetic nephropathies | MNDR-E-MI-37338 |
| MNDR | hsa-miR-30c-5p | Ependymoma | MNDR-E-MI-37339 |
| MNDR | hsa-miR-30c-5p | Cardiac hypertrophy | MNDR-E-MI-37340 |
| MNDR | hsa-miR-30c-5p | Nasopharyngeal cancer | MNDR-E-MI-37341 |
| MNDR | hsa-miR-30c-5p | Prostatic neoplasms | MNDR-E-MI-37342 |
| MNDR | hsa-miR-30c-5p | Sclerosis | MNDR-E-MI-37343 |
| MNDR | hsa-miR-30c-5p | Sleep deprivation | MNDR-E-MI-37344 |
| MNDR | hsa-miR-30c-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-37345 |
| MNDR | hsa-miR-30c-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-37346 |
| MNDR | hsa-miR-30c-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-37347 |
| MNDR | hsa-miR-30c-5p | Stroke lacunar | MNDR-E-MI-37348 |
| MNDR | hsa-miR-30c-5p | Non-alcoholic fatty liver disease | MNDR-E-MI-37349 |
| MNDR | hsa-miR-30c-5p | Breast cancer her3+ negative | MNDR-E-MI-37350 |
| MNDR | hsa-miR-30c-5p | Cerebellar neurodegeneration | MNDR-E-MI-37351 |
| MNDR | hsa-miR-30c-5p | Duke C | MNDR-E-MI-37352 |
| MNDR | hsa-miR-30c-5p | High grade dysplastic nodule | MNDR-E-MI-37353 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | AC254633.1 | Homo sapiens | RR00032112 |
TOP